Update on diagnosis and treatment of actinic keratosis

Actinic keratosis (AK) is a relatively common skin condition occurring due to chronic sun‐exposure, primarily affecting fair skin. Most dermatologists consider it an incipient malignancy due to its risk of full‐blown malignant transformation to squamous cell carcinoma. However, the exact risk factors remain unknown, and thus its course cannot be predicted. Therefore, all cases of AK need early diagnosis and appropriate treatment to mitigate this risk. Over the years, several noninvasive diagnostic techniques such as dermoscopy, reflectance confocal microscopy, and newer treatment modalities (lesion‐directed and field‐directed) have been introduced with their own set of advantages and disadvantages. Notably, invasive skin biopsy with histopathology remains the gold‐standard for diagnosis. Prevention is of paramount importance, highlighted by adequate sun‐protection measures. This article reviews the diagnostic and treatment modalities of AK, with their latest updates, to optimize patient management.

[1]  S. Feldman,et al.  1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses , 2021, The Annals of pharmacotherapy.

[2]  D. Hartmann,et al.  In-Vivo LC-OCT Evaluation of the Downward Proliferation Pattern of Keratinocytes in Actinic Keratosis in Comparison with Histology: First Impressions from a Pilot Study , 2021, Cancers.

[3]  S. Forman,et al.  Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. , 2021, The New England journal of medicine.

[4]  S. Feldman,et al.  Ingenol Mebutate and the Treatment of Actinic Keratosis. , 2020, Journal of drugs in dermatology : JDD.

[5]  M. Lebwohl,et al.  Tirbanibulin Ointment 1% for Actinic Keratosis (AK): Pooled Data from Two Phase 3 Studies , 2020 .

[6]  Bo Hu,et al.  A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination. , 2020, Journal of the American Academy of Dermatology.

[7]  I. Zalaudek,et al.  Current therapies for actinic keratosis , 2020, International journal of dermatology.

[8]  T. Russo,et al.  Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial , 2019, Current medical research and opinion.

[9]  T. Gambichler,et al.  Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses , 2018, The British journal of dermatology.

[10]  T. Gambichler,et al.  Actinic keratoses show variable histological basal growth patterns – a proposed classification adjustment , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  Giovanni Pellacani,et al.  Actinic Keratosis and Non-Invasive Diagnostic Techniques: An Update , 2018, Biomedicines.

[12]  M. Weinstock,et al.  Current perspective on actinic keratosis: a review , 2017, The British journal of dermatology.

[13]  K. Peris,et al.  Italian expert consensus for the management of actinic keratosis in immunocompetent patients , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  B. Sporbeck,et al.  Methods and Results Report – Evidence and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis –International League of Dermatological Societies in cooperation with the European Dermatology Forum , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  G. Fabbrocini,et al.  How to treat actinic keratosis? An update. , 2015, Journal of dermatological case reports.

[16]  Praven Chetty,et al.  Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global Perspective , 2015, Dermatology and Therapy.

[17]  B. Ortel,et al.  Cryotherapy is preferable to ablative CO2 laser for the treatment of isolated actinic keratoses of the face and scalp: a randomized clinical trial , 2014, The British journal of dermatology.

[18]  Scott C Davis,et al.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy , 2013, Photonics & lasers in medicine.

[19]  C. Cockerell,et al.  Pharmacotherapeutic Management of Actinic Keratosis: Focus on Newer Topical Agents , 2013, American Journal of Clinical Dermatology.

[20]  S. Amini,et al.  Pharmacotherapy of actinic keratosis: an update , 2012, Expert opinion on pharmacotherapy.

[21]  B. N. Akay,et al.  Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna , 2010, The British journal of dermatology.

[22]  S. Chimenti,et al.  Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel , 2010, American Journal of Clinical Dermatology.

[23]  Salvador González,et al.  Clinical Applicability of in vivo Reflectance Confocal Microscopy for the Diagnosis of Actinic Keratoses , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[24]  H. Kerl,et al.  Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification , 2007, The British journal of dermatology.

[25]  R. Hofmann-Wellenhof,et al.  Dermoscopy of facial nonpigmented actinic keratosis , 2006, The British journal of dermatology.

[26]  M. Gold,et al.  Current treatments of actinic keratosis. , 2006, Journal of drugs in dermatology : JDD.

[27]  D. Alberts,et al.  Investigating Sun-damaged Skin and Actinic Keratosis with Optical Coherence Tomography: A Pilot Study , 2003, Technology in cancer research & treatment.

[28]  D. Battistutta,et al.  Incidence and determinants of skin cancer in a high‐risk australian population , 1990, International journal of cancer.

[29]  D. Nashan,et al.  Therapeutic strategies for actinic keratoses--a systematic review. , 2013, European journal of dermatology : EJD.

[30]  C. Cockerell,et al.  New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). , 2005, Journal of drugs in dermatology : JDD.